Gold prices are modestly up in early U.S. trading, as the near-term technical posture for the yellow metal is bullish.
Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics
Novamind announces a definitive agreement to acquire Arizona-based Foundations for Change, PLC.
The Military Mental Health Crisis, A National Tragedy: Part II
In Part II, we take a personal look at the journey into PTSD Hell. We also examine the additional serious issues facing veterans attempting to cope with PTSD.
Gold, silver gain amid friendly outside markets
Gold and silver prices are moderately higher in midday U.S. trading Wednesday.
Mydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital Therapeutic Platform Aiming to Further Increase Safety, Efficacy, and Accessibility of Psychedelic-Assisted Treatments
Mydecine announces an LOI to co-develop its own digital therapeutics platform, in partnership with Maya Health.
Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
Optimi Health receives its Health Canada Dealers' License and initiates new Quality Assurance Department.
Cybin Provides 2021 Year End Summary
Cybin Inc provides a year-end update highlighting drug and IP development as well as international expansion.
Gold price holds steady as investors assess omicron risk
Gold prices held steady, hovering close to a three-week peak, as the spread of the omicron coronavirus variant continues to smother investors’ appetite for riskier assets, lifting bullion’s safe-haven appeal.
Price rebounds for gold, silver; risk aversion recedes
A rebound in the crude oil market today and a weaker U.S. dollar index are friendly outside market forces supporting the metals.
The Year In Review For Psychedelic Drug Stocks: 2021
2021 was two different "years" for the psychedelic drug industry. Impressive progress in drug R&D and clinics; stocks pushed down to absurdly lean multiples.
Gold price rallies amid keener risk aversion
Gold prices are posting solid gains and hit a three-week high in early U.S. trading.
COMPASS Selected for Addition to NASDAQ Biotechnology Index
Compass Pathways has been added to the NASDAQ Biotechnology Index (NASDAQ: NBI), tracking the performance of NASDAQ biotechnology/pharmaceutical companies.
